GemPharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	323.1	486.62	701.37	560.17	421.71	293.52
Short-Term Investments	-	23.06	-	120.1	-	-
Trading Asset Securities	714.81	757.69	467.34	637.72	791.24	205.8
Cash & Short-Term Investments	1,038	1,267	1,169	1,318	1,213	499.31
Cash Growth	-18.89%	8.44%	-11.33%	8.66%	142.92%	-4.75%
Accounts Receivable	422.52	384.96	350.81	269.39	185.45	118.57
Other Receivables	4.61	4.24	6.28	6.09	3.63	39.68
Receivables	427.13	389.2	357.09	275.48	189.08	158.25
Inventory	95.88	72.96	54.2	47.09	49.47	30.08
Prepaid Expenses	-	-	-	-	-	3.41
Other Current Assets	140.93	21.94	129.78	16.96	15.51	15.87
Total Current Assets	1,702	1,751	1,710	1,658	1,467	706.93
Property, Plant & Equipment	679.64	693.72	626.28	624.9	375.15	232.78
Long-Term Investments	102.72	282.23	109.05	175.53	306.94	30.08
Other Intangible Assets	68.59	71.37	49.05	47.34	48.51	49.53
Long-Term Deferred Tax Assets	32.3	33.14	35.98	31.85	17.05	4.81
Long-Term Deferred Charges	25.55	28.48	40.58	36.68	19.29	24.63
Other Long-Term Assets	228.43	4.65	1.94	3.77	19.77	5.66
Total Assets	2,839	2,865	2,573	2,578	2,254	1,054

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	74.24	68.13	72.18	101.86	50.79	61.73
Accrued Expenses	40.27	61.24	57.42	50.94	46.56	39.04
Short-Term Debt	138.46	187.33	88.04	76.16	12.21	5.15
Current Portion of Leases	-	23.75	8.82	9.4	2.61	-
Current Income Taxes Payable	14.64	7.07	2.84	14.89	4.09	6.44
Current Unearned Revenue	171.25	176.4	138.23	108.42	89.15	75.91
Other Current Liabilities	5.25	3.22	3.68	4.75	8.66	3.47
Total Current Liabilities	469.13	527.14	371.2	366.41	214.07	191.74
Long-Term Debt	-	-	-	-	-	20.03
Long-Term Leases	70.12	80.23	35.62	36.07	3.05	0.02
Long-Term Unearned Revenue	25.44	22.56	22.9	41.04	48.99	50.49
Long-Term Deferred Tax Liabilities	8.01	7.93	8.2	9.41	9.9	6.5
Total Liabilities	572.7	637.87	437.92	452.93	276	268.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	410	410	410	410	410	360
Additional Paid-In Capital	1,258	1,253	1,261	1,258	1,254	276.73
Retained Earnings	606.07	572.95	487.61	455.4	313.3	148.63
Treasury Stock	-16.02	-16.02	-32.67	-	-	-
Comprehensive Income & Other	8.06	7.07	8.64	1.09	0.91	0.27
Total Common Equity	2,266	2,227	2,135	2,125	1,978	785.63
Shareholders' Equity	2,266	2,227	2,135	2,125	1,978	785.63
Total Liabilities & Equity	2,839	2,865	2,573	2,578	2,254	1,054

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	233.6	291.31	132.48	121.62	17.86	25.2
Net Cash (Debt)	804.31	976.06	1,036	1,196	1,195	474.11
Net Cash Growth	-17.07%	-5.81%	-13.39%	0.11%	152.07%	-8.68%
Net Cash Per Share	1.99	2.40	2.55	2.94	3.05	1.33
Filing Date Shares Outstanding	428.32	408.97	407.41	410	410	410
Total Common Shares Outstanding	428.32	408.97	407.41	410	410	360
Working Capital	1,233	1,224	1,339	1,291	1,253	515.19
Book Value Per Share	5.29	5.45	5.24	5.18	4.82	2.18
Tangible Book Value	2,198	2,156	2,086	2,077	1,929	736.1
Tangible Book Value Per Share	5.13	5.27	5.12	5.07	4.71	2.04
Buildings	-	430.58	324.85	311.67	97.08	97.78
Machinery	-	278.89	263.75	229.67	129.2	93.79
Construction In Progress	-	22.46	90.85	89.6	171.67	53.02